JP2023500060A5 - - Google Patents
Info
- Publication number
- JP2023500060A5 JP2023500060A5 JP2022523485A JP2022523485A JP2023500060A5 JP 2023500060 A5 JP2023500060 A5 JP 2023500060A5 JP 2022523485 A JP2022523485 A JP 2022523485A JP 2022523485 A JP2022523485 A JP 2022523485A JP 2023500060 A5 JP2023500060 A5 JP 2023500060A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962924556P | 2019-10-22 | 2019-10-22 | |
| EP19000483 | 2019-10-22 | ||
| EP19000483.8 | 2019-10-22 | ||
| US62/924,556 | 2019-10-22 | ||
| EP20163777 | 2020-03-17 | ||
| EP20163777.4 | 2020-03-17 | ||
| EP20176336.4 | 2020-05-25 | ||
| EP20176336 | 2020-05-25 | ||
| PCT/EP2020/079802 WO2021078889A1 (en) | 2019-10-22 | 2020-10-22 | Methods and compositions for treating sickle cell disease with a ferroportin inhibitor (vit-2763) |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023500060A JP2023500060A (ja) | 2023-01-04 |
| JP2023500060A5 true JP2023500060A5 (https=) | 2023-06-06 |
| JPWO2021078889A5 JPWO2021078889A5 (https=) | 2023-06-06 |
| JP7594004B2 JP7594004B2 (ja) | 2024-12-03 |
Family
ID=73005635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523485A Active JP7594004B2 (ja) | 2019-10-22 | 2020-10-22 | フェロポーチン阻害剤（ｖｉｔ－２７６３）を用いる鎌状赤血球症を治療するための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220274973A1 (https=) |
| EP (1) | EP4048262A1 (https=) |
| JP (1) | JP7594004B2 (https=) |
| KR (1) | KR20220086563A (https=) |
| CN (1) | CN114765955B (https=) |
| AU (1) | AU2020369137A1 (https=) |
| BR (1) | BR112022007616A2 (https=) |
| CA (1) | CA3154524A1 (https=) |
| IL (1) | IL291137A (https=) |
| MX (1) | MX2022004806A (https=) |
| WO (1) | WO2021078889A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025535398A (ja) | 2022-10-21 | 2025-10-24 | ビフォー （インターナショナル） エージー | 二環式フェロポーチン阻害剤 |
| EP4731218A1 (en) | 2023-06-26 | 2026-04-29 | Vifor (International) AG | Ferroportin-inhibitors for the use in the treatment of hereditary haemochromatosis (hh) |
| WO2026041650A1 (en) | 2024-08-20 | 2026-02-26 | Vifor (International) Ag | Ferroportin-inhibitors for the use in the treatment of lupus nephritis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3002416C (en) | 2015-10-23 | 2023-10-24 | Vifor (International) Ag | Benzimidazolyl derivatives for use as ferroportin inhibitors |
| US11191818B2 (en) * | 2016-08-04 | 2021-12-07 | Takeda Pharmaceutical Company Limited | Use of ADAMTS13 for treating, ameliorating and/or preventing vaso-occlusive crisis in sickle cell disease, acute lung injury and/or acute respiratory distress syndrome |
| JOP20180036A1 (ar) * | 2017-04-18 | 2019-01-30 | Vifor Int Ag | أملاح لمثبطات فروبورتين جديدة |
| ES2934492T3 (es) | 2018-12-13 | 2023-02-22 | Global Blood Therapeutics Inc | Inhibidores de ferroportina y métodos de uso |
-
2020
- 2020-10-22 AU AU2020369137A patent/AU2020369137A1/en active Pending
- 2020-10-22 JP JP2022523485A patent/JP7594004B2/ja active Active
- 2020-10-22 EP EP20796575.7A patent/EP4048262A1/en active Pending
- 2020-10-22 MX MX2022004806A patent/MX2022004806A/es unknown
- 2020-10-22 BR BR112022007616A patent/BR112022007616A2/pt unknown
- 2020-10-22 US US17/636,575 patent/US20220274973A1/en not_active Abandoned
- 2020-10-22 CA CA3154524A patent/CA3154524A1/en active Pending
- 2020-10-22 CN CN202080074094.0A patent/CN114765955B/zh active Active
- 2020-10-22 WO PCT/EP2020/079802 patent/WO2021078889A1/en not_active Ceased
- 2020-10-22 KR KR1020227012237A patent/KR20220086563A/ko active Pending
-
2022
- 2022-03-06 IL IL291137A patent/IL291137A/en unknown